Magnetic resonance imaging for the diagnosis of acute leukoencephalopathy in children treated with tacrolimus

Neuropediatrics

Volumn 35, Issue 2, 2004, Pages 130-133

  Lacaille, Florence ^a   Hertz Pannier, L ^a   Nassogne, M C ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Leukoencephalopathy; Magnetic resonance imaging; Tacrolimus

Indexed keywords

AZATHIOPRINE; COTRIMOXAZOLE; FLUCONAZOLE; GANCICLOVIR; LABETALOL; NICARDIPINE; PREDNISONE; STEROID; TACROLIMUS;

ARTICLE; CASE REPORT; COMA; CONTROLLED STUDY; DEMYELINATION; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; DRUG INDUCED DISEASE; EDEMA; FEMALE; FLUID ATTENUATED INVERSION RECOVERY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEARNING DISORDER; LEUKOENCEPHALOPATHY; MALE; NEUROLOGICAL COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PRIORITY JOURNAL; SEIZURE; TRANSPLANTATION;

ACUTE DISEASE; BRAIN; CHILD, PRESCHOOL; COMA; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE IMAGING; MALE; SEIZURES; TACROLIMUS;

EID: 2442600142     PISSN: 0174304X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-815835     Document Type: Article

References (12)

1. Bonham CA, Dominguez EA, Fukui MB et al. Central nervous system lesions in liver transplant recipients: prospective assessment of indications for biopsy and implications for management. Transplantation 1998; 66: 1596-1604
2. De Groen PC, Aksamit AJ, Rakela J, Forbes GS, Krom RAF. Central nervous system toxicity after liver transplantation. The role of ciclosporine and cholesterol. N Engl J Med 1987; 317: 861-866
3. Filley CM, Kleinschmidt-DeMasters BK. Toxic leukoencephalopathy. N Engl J Med 2001; 345: 425-432
4. Frúhauf NR, Koeppen S, Saner FH, Egelhof T, Stavrou G, Nadalin S, Broelsch CE. Late onset of tacrolimus-related posterior leukoencephalopathy after living donor liver transplantation. Liver Transpl 2003; 9: 983-985
5. Kochi S, Takanaga H, Matsuo H, Naito M, Tsuruo T, Sawada Y. Effect of cyclosporin A or tacrolimus on the function of blood-brain barrier cells. Eur J Pharmacol 1999; 372: 287-295
6. Menegaux F, Keeffe EB, Andrews BT et al. Neurological complications of liver transplantation in adult versus pediatric patients. Transplantation 1994; 58: 447-450
7. Parvex P, Pinsk M, Bell LE, O'Gorman AMG, Patenaude YG, Gupta IR. Reversible encephalopathy associated with tacrolimus in pediatric renal transplants. Pediatr Nephrol 2001; 16: 537-542
8. Romero JM, Schaefer PW, Grant PE, Becerra L, Gonzalez RG. Diffusion MR imaging of acute ischemic stroke. Neuroimaging Clin N Am 2002; 12: 35-53
9. Singh N, Bonham A, Fukui M. Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. Transplantation 2000; 69: 467-472
10. Small S, Fukui M, Bramblett GT, Eidelman BH. Immunosuppression-induced leukoencephalopathy from tacrolimus (FK506). Ann Neurol 1996; 40: 575-580
11. Torocsik HV, Curless RG, Post J, Tzakis AG, Pearse L. FK506-induced leukoencephalopathy in children with organ transplants. Neurology 1999; 52: 1497-1500
12. Wijdicks EF, Wiesner RH, Dahlke LJ, Krom RA. FK506-induced neurotoxicity in liver transplantation. Ann Neurol 1994; 35: 498-501